FINEARTS-HF: Improving outcomes in heart failure with preserved or mildly reduced ejection fraction

= .007), primarily by lowering admissions for heart failure. Finerenone is the first mineralocorticoid receptor antagonist to improve outcomes in this patient population.

Authors

Institutions

Publication Details

Journal
Cleveland Clinic Journal of Medicine
Published
2026-05-01
DOI
https://doi.org/10.3949/ccjm.93a.25081
Primary Topic
Hormonal Regulation and Hypertension
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FINEARTS-HF: Improving outcomes in heart failure with preserved or mildly reduced ejection fraction

Salman Salahuddin
Cleveland Clinic Journal of Medicine
Hormonal Regulation and Hypertension
article

FINEARTS-HF: Improving outcomes in heart failure with preserved or mildly reduced ejection fraction

Salman Salahuddin
article en

Abstract

= .007), primarily by lowering admissions for heart failure. Finerenone is the first mineralocorticoid receptor antagonist to improve outcomes in this patient population.

Cleveland Clinic Journal of MedicineVol. 93(5)
Malabar Institute of Medical Sciences (IN)
Good health and well-being
Openalex Percentile: Top 11%
Hormonal Regulation and Hypertension
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

FINEARTS-HF: Improving outcomes in heart failure with preserved or mildly reduced ejection fraction — Salman Salahuddin · Cleveland Clinic Journal of Medicine (2026) | TGRS Research Map | TGRS